rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CODX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Co-Diagnostics receives test order from Peru amid dengue rise
      Nov 17Investing.comCODX
      Co-Diagnostics Receives Logix Smart® ZDC Test Order from Peru Distributor as Dengue Cases Rise and Exhibits at MEDICA 2026 in Düsseldorf
      Nov 17Yahoo FinanceCODX
      Earnings call transcript: Co-Diagnostics beats Q3 2026 estimates, shares fall
      Nov 10Investing.comCODX
      12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      Nov 10BenzingaCODX
      Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast
      Nov 5Yahoo FinanceCODX
      Co-Diagnostics to Participate in Three Global Tuberculosis Events in November as CoSara Advances Toward Anticipated India Launch

      Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Company will participate in three global tuberculosis ("TB") events in November 2026:

      Nov 5Yahoo FinanceCODX
      Co-Diagnostics joint venture study finds HPV test detected lesions
      Oct 29Investing.comCODX
      Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast

      --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its third quarter 2026 financial results on Thursday, November 12, 2026, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to...

      Oct 29NasdaqCODX
      Co-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® Test
      Oct 29MorningstarCODX
      Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
      Oct 27Yahoo FinanceCODX
      EXCLUSIVE: Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
      Oct 27BenzingaCODX
      Co-Diagnostics joint venture invited to Saudi manufacturing forum
      Oct 20Investing.comCODX
      Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection
      Oct 15MorningstarCODX
      Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe
      Oct 8Yahoo FinanceCODX
      Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development
      Oct 6MorningstarCODX
      Co-Diagnostics annual meeting adjourned again due to lack of quorum
      Sep 25Investing.comCODX
      Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week
      Sep 23MorningstarCODX
      Longhorn Vaccines and Diagnostics Appoints Vijay Singh, PhD, as Chief Scientific Officer
      Sep 22Yahoo FinanceCODX
      Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
      Sep 21Yahoo FinanceCODX
      Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX) and Amgen (AMGN)

      Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

      Sep 18The Globe and MailCODX
      Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026
      Sep 17Yahoo FinanceCODX
      Co-Diagnostics, Inc. (CODX) Shareholder/Analyst Call - Slideshow (NASDAQ:CODX) 2026-09-16
      Sep 16Seeking AlphaCODX
      Co-Diagnostics partners with ReadyGo on blood-based testing
      Sep 16Investing.comCODX
      Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
      Sep 16Yahoo FinanceCODX
      Co-Diagnostics enters agreement with ReadyGo Diagnostics for technology evaluation
      Sep 15Investing.comCODX
      Co-Diagnostics to Hold Press Conference

      Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will host a press conference and live webcast Wednesday, Sept. 16, 2026, at 10:30 a.m. Eastern Time.

      Sep 15Yahoo FinanceCODX
      Co-Diagnostics Appoints New Principal Financial Officer

      Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

      Sep 5The Globe and MailCODXPFG
      Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
      Sep 3MorningstarCODX
      Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
      Sep 1MorningstarCODX

      This is the newest page. Registered accounts read further back.